Moreover, immunoblotting using CD90-positive MYOD1-UDCs from DMD patients with exon 45 deletion should support detecting stably high intense bands of dystrophin under treatment of the exon 44 skipping ASO. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.